Aurora kinase A
Details
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB02482 Phosphonothreonine experimental unknown Details DB05220 Alisertib investigational unknown inhibitorregulator Details DB05198 CYC116 investigational unknown Details DB05169 AT9283 investigational unknown Details DB06134 SNS-314 investigational unknown Details DB13061 MLN8054 investigational unknown Details DB06347 Cenisertib investigational unknown Details DB06486 Enzastaurin investigational unknown Details DB07186 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE experimental unknown Details DB07266 AKI-001 experimental unknown Details DB07360 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea experimental unknown Details DB07362 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea experimental unknown Details DB07545 N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE experimental unknown Details DB07801 N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide experimental unknown Details DB08065 2-(1H-pyrazol-3-yl)-1H-benzimidazole experimental unknown Details DB08066 N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE experimental unknown Details DB12010 Fostamatinib approved, investigational unknown inhibitor Details DB12556 MK-5108 investigational unknown regulator Details